Inventor · disambiguated record
Pan-Chyr Yang
Also filed as: YANG PAN · YANG PAN-CHYR
32 granted patents·14 pending applications·129 citations·filing 1996–2023
94Inventor score
Top patents by PatentIndex Score
46 records- 0179US7745134B2Predicting post-treatment survival in cancer patients with microRNAsUNIV NAT TAIWAN·Filed 2008·Granted Jun 29, 2010·2 cites·6 claims
- 0278US7507534B2Rapid efficacy assessment method for lung cancer therapyNAT HEALTH RESEARCH INSTITUTES·Filed 2005·Granted Mar 24, 2009·2 cites·2 claims
- 0376US2024018484A1Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemnessUNIV NAT TAIWAN·Filed 2023·Application pending·0 cites
- 0474US6218114B1Methods for detecting differentially expressed genesACADEMIA SINICA·Filed 1998·Granted Apr 17, 2001·59 cites·12 claims
- 0572US11919886B24,9-dioxo-4,9-dihydronaphtho[2,3-B]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseasesACADEMIA SINICA·Filed 2022·Granted Mar 5, 2024·0 cites·4 claims
- 0672US10155993B2Method or kit for determining lung cancer developmentUNIV NAT TAIWAN·Filed 2016·Granted Dec 18, 2018·1 cites·5 claims
- 0772US7211660B2Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequencesADVPHARMA INC·Filed 2005·Granted May 1, 2007·2 cites·10 claims
- 0872US5789173AMethods for rapid antimicrobial susceptibility testingACADEMIA SINICA·Filed 1996·Granted Aug 4, 1998·52 cites·34 claims
- 0971US7955800B2Metastasis-associated gene profiling for identification of tumor tissue, subtyping, and prediction of prognosis of patientsADVPHARMA INC·Filed 2006·Granted Jun 7, 2011·1 cites·16 claims
- 1070US11834682B2Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemnessUNIV NAT TAIWAN·Filed 2020·Granted Dec 5, 2023·0 cites·17 claims
- 1170US9891227B2Ultrasensitive detection of a biological target by aptamer-conjugated gold nanoparticlesACADEMIA SINICA·Filed 2015·Granted Feb 13, 2018·1 cites·16 claims
- 1269US9216977B2Antofine and cryptopleurine derivatives as anticancer agentsLEE KUO-HSIUNG·Filed 2010·Granted Dec 22, 2015·1 cites·11 claims
- 1369US7354709B2Collapsin response mediator protein-1UNIV NAT TAIWAN·Filed 2002·Granted Apr 8, 2008·6 cites·4 claims
- 1468US7601693B2Composition for treating cancer and use thereofUNIV NAT TAIWAN·Filed 2008·Granted Oct 13, 2009·1 cites·2 claims
- 1567US12109207B2Methods of using 4(1H)-quinolone derivativesACADEMIA SINICA·Filed 2023·Granted Oct 8, 2024·0 cites·34 claims
- 1664US2009220985A1Rapid efficacy assessment method for lung cancer therapyNAT HEALTH RESEARCH INSTITUTES·Filed 2009·Application pending·0 cites
- 1760US10888568B2Pharmaceutical composition for treatment of cancer using phenothiazineHUANG CHI YING·Filed 2018·Granted Jan 12, 2021·0 cites·10 claims
- 1860US8263570B2Treating picornavirus infection by targeting MicroRNA miR-141HO BING-CHING·Filed 2009·Granted Sep 11, 2012·1 cites·13 claims
- 1959US10865388B2Method for identifying anti-cancer agents using an in vitro cell culture system that maintains cancer cell stemnessUNIV NAT TAIWAN·Filed 2014·Granted Dec 15, 2020·0 cites·10 claims
- 2057US12013513B2Metasurface based device for generating abrupt autofocusing beamUNIV NAT TAIWAN·Filed 2021·Granted Jun 18, 2024·0 cites·18 claims
- 2156US11434229B24,9-dioxo-4,9-dihydronaphtho[2,3-b]furan-3-carboxamide derivatives and uses thereof for treating proliferative diseases and infectious diseasesACADEMIA SINICA·Filed 2017·Granted Sep 6, 2022·0 cites·3 claims
- 2256US7655779B2Collapsin response mediator protein-1 (CRMP-1) transcriptional regulatory nucleic acid sequencesADVPHARMA INC·Filed 2007·Granted Feb 2, 2010·0 cites·10 claims
- 2356US2008032282A1Methods and applications of molecular beacon imaging for infectious disease and cancer detectionAL VITAE PHARMACEUTICALS·Filed 2006·Application pending·0 cites
- 2454US11638705B24(1H)-quinolone derivatives and uses thereofACADEMIA SINICA·Filed 2020·Granted May 2, 2023·0 cites·29 claims
- 2553US8450283B2Composition for treating cancer and use thereofYANG PAN-CHYR·Filed 2009·Granted May 28, 2013·0 cites·6 claims
- 2653US2012029018A19-substituted phenanthrene based tylophorine derivativesLEE KUO-HSIUNG·Filed 2009·Application pending·0 cites
- 2751US2015141485A1PROGNOSIS AND TREATMENT OF LUNG CANCER USING miRNA-135bUNIV NAT CHENG KUNG·Filed 2013·Application pending·0 cites
- 2850US12326205B2Pipeline, pipeline connector, and liquid chromatography systemMAXI SCIENT INSTRUMENTS SUZHOU CO LTD·Filed 2023·Granted Jun 10, 2025·0 cites·17 claims
- 2950US11447778B2TNF-targeting aptamers and uses thereof for treatment or diagnosing TNF-related inflammatory diseasesACADEMIA SINICA·Filed 2018·Granted Sep 20, 2022·0 cites·28 claims
- 3050US11214774B2PINK1 C-terminal domain polypeptide and methods using the same in cancer treatmentWO ANDREW MAN CHUNG·Filed 2016·Granted Jan 4, 2022·0 cites·7 claims
- 3148US9856480B2Dnazyme for silencing the expression of EGFRDCB-USA LLC·Filed 2014·Granted Jan 2, 2018·0 cites·24 claims
- 3248US2020368336A1Method for preparing personalized cancer vaccineSHANGHAI JENOMED BIOTECH CO LTD·Filed 2018·Application pending·0 cites
- 3346US10329570B2Antagonistic PD-1 aptamer and its applications in cancer therapy related applicationsACADEMIA SINICA·Filed 2015·Granted Jun 25, 2019·0 cites·31 claims
- 3444US12085570B2Biomarkers for lung cancer stem cellsUNIV NAT TAIWAN·Filed 2018·Granted Sep 10, 2024·0 cites·12 claims
- 3543US2006194235A1HLJ1 gene expressionCHEN JIAN-WEI·Filed 2006·Application pending·0 cites
- 3643US2016289678A1Use of microrna 146-a in the diagnosis, treatment and prevention of picornavirus infection and microrna 146-a antagonistsDCB-USA LLC·Filed 2014·Application pending·0 cites
- 3743US2023235007A1Humanized ace2-fc fusion protein for treatment and prevention of sars-cov-2 infectionSHIH MING CHE·Filed 2021·Application pending·0 cites
- 3843US2016120876A1Pharmaceutical composition for treatment of cancer using phenothiazineHUANG CHI-YING·Filed 2015·Application pending·0 cites
- 3942US2014242580A1Method for predicting response or prognosis of lung adenocarcinoma with egfr-activating mutationsYU SUNG-LIANG·Filed 2012·Application pending·0 cites
- 4041US10765681B2Purine compounds possessing anticancer activityACADEMIA SINICA·Filed 2017·Granted Sep 8, 2020·0 cites·19 claims
- 4141US10584341B2Antagonistic PDL1 aptamers and their applications in cancer therapyACADEMIA SINICA·Filed 2016·Granted Mar 10, 2020·0 cites·23 claims
- 4241US2011224205A1Use of curcumin or its analogues in cancer therapy utilizing epidermal growth factor receptor tyrosine kinase inhibitorUNIV NAT TAIWAN·Filed 2011·Application pending·0 cites
- 4338US2003054387A1Metastasis-associated genesFiled 2002·Application pending·0 cites
- 4436US11891447B2Method for treating cancer using CD14 antagonistsCHEN HUEI WEN·Filed 2018·Granted Feb 6, 2024·0 cites·12 claims
- 4535US2019275345A1Remote control of light-triggered virotherapyACADEMIA SINICA·Filed 2017·Application pending·0 cites
- 4630US10533179B2Antagonistic CTLA-4 aptamers and applications thereof in enhancing immune activityACADEMIA SINICA·Filed 2015·Granted Jan 14, 2020·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when Pan-Chyr Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →